VEGF and Hypoxia Independently Induce MDR1 Expression to Promote Endothelial Cell Angiogenesis

Area of Science:

• Endothelial biology
• Molecular mechanisms of angiogenesis
• Cancer progression

Background:

• Angiogenesis is crucial for endothelial biology and tumor growth, regulated by VEGF and hypoxia.
• Multidrug Resistance Protein 1 (MDR1) is known for drug efflux but also implicated in endothelial function.
• The independent roles of VEGF and hypoxia in regulating MDR1 expression and function in angiogenesis require investigation.

Purpose of the Study:

• To determine if VEGF and hypoxia independently regulate MDR1 expression in human umbilical vein endothelial cells (HUVECs).
• To investigate the functional significance of MDR1 in the process of angiogenesis.
• To explore the signaling pathways involved in MDR1 regulation by VEGF and hypoxia.

Main Methods:

• HUVECs were treated with VEGF or exposed to hypoxia (1% O2 or CoCl2).
• MDR1 expression was quantified using qRT-PCR, Western blotting, flow cytometry, and immunofluorescence.
• Functional assays (migration, invasion, tube formation, viability) were performed with MDR1 overexpression or knockdown; HIF-1α overexpression was used to study hypoxia effects.

Main Results:

• VEGF dose- and time-dependently induced MDR1 expression, localized intracellularly without enhancing drug efflux.
• MDR1 overexpression enhanced endothelial migration, invasion, tube formation, and viability independently of VEGF.
• MDR1 knockdown reduced VEGF-induced angiogenic responses.
• Hypoxia and HIF-1α overexpression independently upregulated MDR1 expression.

Conclusions:

• VEGF and hypoxia independently induce MDR1 expression in endothelial cells via distinct pathways.
• MDR1 is a key mediator of angiogenesis, separate from its drug efflux activity.
• MDR1 represents a potential therapeutic target for angiogenesis-related vascular diseases.